Growth Metrics

Globus Medical (GMED) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $5.1 billion.

  • Globus Medical's Liabilities and Shareholders Equity rose 18.87% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 billion, marking a year-over-year decrease of 44.71%. This contributed to the annual value of $5.3 billion for FY2024, which is 325.73% up from last year.
  • Globus Medical's Liabilities and Shareholders Equity amounted to $5.1 billion in Q3 2025, which was up 18.87% from $5.0 billion recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Liabilities and Shareholders Equity registered a high of $5.4 billion during Q3 2023, and its lowest value of $1.7 billion during Q1 2021.
  • Over the past 5 years, Globus Medical's median Liabilities and Shareholders Equity value was $2.2 billion (recorded in 2023), while the average stood at $3.4 billion.
  • As far as peak fluctuations go, Globus Medical's Liabilities and Shareholders Equity soared by 17097.61% in 2023, and later crashed by 503.8% in 2024.
  • Quarter analysis of 5 years shows Globus Medical's Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then rose by 6.07% to $2.1 billion in 2022, then soared by 144.98% to $5.1 billion in 2023, then rose by 3.26% to $5.3 billion in 2024, then fell by 2.97% to $5.1 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $5.1 billion for Q3 2025, versus $5.0 billion for Q2 2025 and $4.7 billion for Q1 2025.